Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey


Kartal O., Gulec M., Caliskaner Z., Musabak U., Sener O.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, vol.37, no.3, pp.280-286, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.3109/08923973.2015.1027918
  • Journal Name: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.280-286

Abstract

Context: Although subcutaneous allergen immunotherapy (SCIT) is effective in allergic rhinitis (AR) and asthma, it carries a risk of local and systemic adverse reactions.